102 related articles for article (PubMed ID: 8255988)
1. Eegraphic and behavioural effects of ondansetron, a 5HT3 antagonist, in rabbits.
Bo P; Marchioni E; Soragna D; Murelli R; Savoldi F
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):801-23. PubMed ID: 8255988
[TBL] [Abstract][Full Text] [Related]
2. Influence of L-5-hydroxytryptophan and DL-p-chlorophenylalanine on neurophysiological profiles of serotonin reuptake inhibitors in rabbits.
Bo P; Patrucco M; Maurelli M; Camana C; Savoldi F
Farmaco Sci; 1987 Aug; 42(8):595-601. PubMed ID: 2959563
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of EEGraphic and behavioural effects of methamphetamine by selective receptor blockers (SCH 23390 and raclopride) in the rabbit.
Bo P; Marchioni E; Dallocchio C; Albergati A; Savoldi F
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):803-15. PubMed ID: 1837158
[TBL] [Abstract][Full Text] [Related]
4. Neuropharmacological profile of ketanserin.
Bo P; Patrucco M; Savoldi F
Farmaco Sci; 1987 Feb; 42(2):91-9. PubMed ID: 3494632
[TBL] [Abstract][Full Text] [Related]
5. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
6. Neurophysiological changes induced by 5-HT reuptake inhibitors in rabbits.
Bo P; Patrucco M; Maurelli M; Camana C; Savoldi F
Farmaco Sci; 1987 Jul; 42(7):505-12. PubMed ID: 3666124
[TBL] [Abstract][Full Text] [Related]
7. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.
Cheng CH; Costall B; Kelly ME; Naylor RJ
Eur J Pharmacol; 1994 Apr; 255(1-3):39-49. PubMed ID: 7913044
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.
Pei Q; Zetterström T; Leslie RA; Grahame-Smith DG
Eur J Pharmacol; 1993 Jan; 230(1):63-8. PubMed ID: 8381355
[TBL] [Abstract][Full Text] [Related]
9. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
Gupta D; Radhakrishnan M; Kurhe Y
Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
[TBL] [Abstract][Full Text] [Related]
10. Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.
Rodgers RJ; Cole JC; Tredwell JM
Psychopharmacology (Berl); 1995 Feb; 117(3):306-12. PubMed ID: 7770606
[TBL] [Abstract][Full Text] [Related]
11. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
Roychoudhury M; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):107-11. PubMed ID: 9151286
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.
Warburton EC; Joseph MH; Feldon J; Weiner I; Gray JA
Psychopharmacology (Berl); 1994 May; 114(4):657-64. PubMed ID: 7855229
[TBL] [Abstract][Full Text] [Related]
13. Synchronizing EEG effect of mianserin.
Bo P; Patrucco M; Savoldi F; Lottici P
Farmaco Sci; 1985 Dec; 40(12):909-20. PubMed ID: 2936620
[TBL] [Abstract][Full Text] [Related]
14. 5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats.
Arnold B; Allison K; Ivanová S; Paetsch PR; Paslawski T; Greenshaw AJ
Psychopharmacology (Berl); 1995 May; 119(2):213-21. PubMed ID: 7659769
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha helical CRF 9-41 on neurophysiological and autonomic patterns induced by CRF in the rabbit.
Marchioni E; Maurelli M; Tartara A
Boll Soc Ital Biol Sper; 1993 Apr; 69(4):265-72. PubMed ID: 8129907
[TBL] [Abstract][Full Text] [Related]
16. Improved p50 auditory gating with ondansetron in medicated schizophrenia patients.
Adler LE; Cawthra EM; Donovan KA; Harris JG; Nagamoto HT; Olincy A; Waldo MC
Am J Psychiatry; 2005 Feb; 162(2):386-8. PubMed ID: 15677607
[TBL] [Abstract][Full Text] [Related]
17. Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat.
Lane JD; Pickering CL; Hooper ML; Fagan K; Tyers MB; Emmett-Oglesby MW
Drug Alcohol Depend; 1992 Jun; 30(2):151-62. PubMed ID: 1386019
[TBL] [Abstract][Full Text] [Related]
18. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist.
Colpaert FC; Janssen PA
Neuropharmacology; 1983 Aug; 22(8):993-1000. PubMed ID: 6604885
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice.
Umathe SN; Bhutada PS; Raut VS; Jain NS; Mundhada YR
Behav Pharmacol; 2009 Feb; 20(1):78-83. PubMed ID: 19106764
[TBL] [Abstract][Full Text] [Related]
20. Experimental study on central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA).
Bo P; Camana C; Curti M; Fussi F; Giorgetti A; Savoldi F
Farmaco Sci; 1988 Apr; 43(4):363-72. PubMed ID: 3264535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
